APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Antidiabetic Sulphonylureas

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Antidiabetic Sulphonylureas Market Outlook and Growth Opportunities 2026

Report ID 173966080420 December 2025199 pages

Choose your research edition.

Industry ResearchAntidiabetic Sulphonylureas Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Antidiabetic Sulphonylureas Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Antidiabetic Sulphonylureas Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antidiabetic Sulphonylureas Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Antidiabetic Sulphonylureas Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Antidiabetic Sulphonylureas market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Antidiabetic Sulphonylureas is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Antidiabetic Sulphonylureas is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antidiabetic Sulphonylureas is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Antidiabetic Sulphonylureas market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Antidiabetic Sulphonylureas market include Boehringer Ingelheim, Bristol-Myers Squibb, Novo Nordisk, Servier Laboratories, AstraZeneca, GlaxoSmithKline, Pfizer, Eli Lilly and Merck & Co, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Antidiabetic Sulphonylureas market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antidiabetic Sulphonylureas and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antidiabetic Sulphonylureas sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Antidiabetic Sulphonylureas market size, projected growth trends, production technologies, key applications, and end-use industries.

Antidiabetic Sulphonylureas Segment by Company

Boehringer Ingelheim

Bristol-Myers Squibb

Novo Nordisk

Servier Laboratories

AstraZeneca

GlaxoSmithKline

Pfizer

Eli Lilly

Merck & Co

Sanofi

Takeda Pharmaceuticals

Antidiabetic Sulphonylureas Segment by Type

First Generation Antidiabetic Sulphonylureas

The Second Generation Antidiabetic Sulphonylureas

The Third Generation Antidiabetic Sulphonylureas

Antidiabetic Sulphonylureas Segment by Application

Hospitals

Clinics

Other

Antidiabetic Sulphonylureas Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Antidiabetic Sulphonylureas status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Antidiabetic Sulphonylureas market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Antidiabetic Sulphonylureas significant trends, drivers, influence factors in global and regions.

6. To analyze Antidiabetic Sulphonylureas competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antidiabetic Sulphonylureas market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antidiabetic Sulphonylureas and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antidiabetic Sulphonylureas.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Antidiabetic Sulphonylureas market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Antidiabetic Sulphonylureas industry.

Chapter 3: Detailed analysis of Antidiabetic Sulphonylureas manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Antidiabetic Sulphonylureas in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Antidiabetic Sulphonylureas in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Antidiabetic Sulphonylureas Industry Trends Table 2. Antidiabetic Sulphonylureas Industry Drivers Table 3. Antidiabetic Sulphonylureas Industry Opportunities and Challenges Table 4. Antidiabetic Sulphonylureas Industry Restraints Table 5. Global Antidiabetic Sulphonylureas Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Antidiabetic Sulphonylureas Revenue Share by Company (2021-2026) Table 7. Global Antidiabetic Sulphonylureas Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Antidiabetic Sulphonylureas Sales Volume Share by Company (2021-2026) Table 9. Global Antidiabetic Sulphonylureas Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Antidiabetic Sulphonylureas Company Ranking, (2024-2026) & (USD Million) Table 11. Global Antidiabetic Sulphonylureas Key Company Manufacturing Base & Headquarters Table 12. Global Antidiabetic Sulphonylureas Company, Product Type & Application Table 13. Global Antidiabetic Sulphonylureas Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Antidiabetic Sulphonylureas by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of First Generation Antidiabetic Sulphonylureas Table 18. Significant Companies of The Second Generation Antidiabetic Sulphonylureas Table 19. Significant Companies of The Third Generation Antidiabetic Sulphonylureas Table 20. Global Antidiabetic Sulphonylureas Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Antidiabetic Sulphonylureas Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Antidiabetic Sulphonylureas Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Antidiabetic Sulphonylureas Sales Volume Share by Type (2021-2026) Table 24. Global Antidiabetic Sulphonylureas Sales Volume Share by Type (2027-2032) Table 25. Global Antidiabetic Sulphonylureas Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Antidiabetic Sulphonylureas Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Antidiabetic Sulphonylureas Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Antidiabetic Sulphonylureas Sales Value Share by Type (2021-2026) Table 29. Global Antidiabetic Sulphonylureas Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospitals Table 31. Significant Companies of Clinics Table 32. Significant Companies of Other Table 33. Global Antidiabetic Sulphonylureas Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Antidiabetic Sulphonylureas Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Antidiabetic Sulphonylureas Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Antidiabetic Sulphonylureas Sales Volume Share by Application (2021-2026) Table 37. Global Antidiabetic Sulphonylureas Sales Volume Share by Application (2027-2032) Table 38. Global Antidiabetic Sulphonylureas Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Antidiabetic Sulphonylureas Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Antidiabetic Sulphonylureas Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Antidiabetic Sulphonylureas Sales Value Share by Application (2021-2026) Table 42. Global Antidiabetic Sulphonylureas Sales Value Share by Application (2027-2032) Table 43. Global Antidiabetic Sulphonylureas Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Antidiabetic Sulphonylureas Sales by Region (2021-2026) & (K Units) Table 45. Global Antidiabetic Sulphonylureas Sales Market Share by Region (2021-2026) Table 46. Global Antidiabetic Sulphonylureas Sales by Region (2027-2032) & (K Units) Table 47. Global Antidiabetic Sulphonylureas Sales Market Share by Region (2027-2032) Table 48. Global Antidiabetic Sulphonylureas Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Antidiabetic Sulphonylureas Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Antidiabetic Sulphonylureas Sales Value Share by Region (2021-2026) Table 51. Global Antidiabetic Sulphonylureas Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Antidiabetic Sulphonylureas Sales Value Share by Region (2027-2032) Table 53. Global Antidiabetic Sulphonylureas Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Antidiabetic Sulphonylureas Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Antidiabetic Sulphonylureas Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Antidiabetic Sulphonylureas Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Antidiabetic Sulphonylureas Sales by Country (2021-2026) & (K Units) Table 58. Global Antidiabetic Sulphonylureas Sales Market Share by Country (2021-2026) Table 59. Global Antidiabetic Sulphonylureas Sales by Country (2027-2032) & (K Units) Table 60. Global Antidiabetic Sulphonylureas Sales Market Share by Country (2027-2032) Table 61. Global Antidiabetic Sulphonylureas Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Antidiabetic Sulphonylureas Sales Value Market Share by Country (2021-2026) Table 63. Global Antidiabetic Sulphonylureas Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Antidiabetic Sulphonylureas Sales Value Market Share by Country (2027-2032) Table 65. Boehringer Ingelheim Company Information Table 66. Boehringer Ingelheim Business Overview Table 67. Boehringer Ingelheim Antidiabetic Sulphonylureas Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Boehringer Ingelheim Antidiabetic Sulphonylureas Product Portfolio Table 69. Boehringer Ingelheim Recent Development Table 70. Bristol-Myers Squibb Company Information Table 71. Bristol-Myers Squibb Business Overview Table 72. Bristol-Myers Squibb Antidiabetic Sulphonylureas Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Bristol-Myers Squibb Antidiabetic Sulphonylureas Product Portfolio Table 74. Bristol-Myers Squibb Recent Development Table 75. Novo Nordisk Company Information Table 76. Novo Nordisk Business Overview Table 77. Novo Nordisk Antidiabetic Sulphonylureas Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Novo Nordisk Antidiabetic Sulphonylureas Product Portfolio Table 79. Novo Nordisk Recent Development Table 80. Servier Laboratories Company Information Table 81. Servier Laboratories Business Overview Table 82. Servier Laboratories Antidiabetic Sulphonylureas Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Servier Laboratories Antidiabetic Sulphonylureas Product Portfolio Table 84. Servier Laboratories Recent Development Table 85. AstraZeneca Company Information Table 86. AstraZeneca Business Overview Table 87. AstraZeneca Antidiabetic Sulphonylureas Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. AstraZeneca Antidiabetic Sulphonylureas Product Portfolio Table 89. AstraZeneca Recent Development Table 90. GlaxoSmithKline Company Information Table 91. GlaxoSmithKline Business Overview Table 92. GlaxoSmithKline Antidiabetic Sulphonylureas Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. GlaxoSmithKline Antidiabetic Sulphonylureas Product Portfolio Table 94. GlaxoSmithKline Recent Development Table 95. Pfizer Company Information Table 96. Pfizer Business Overview Table 97. Pfizer Antidiabetic Sulphonylureas Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Pfizer Antidiabetic Sulphonylureas Product Portfolio Table 99. Pfizer Recent Development Table 100. Eli Lilly Company Information Table 101. Eli Lilly Business Overview Table 102. Eli Lilly Antidiabetic Sulphonylureas Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Eli Lilly Antidiabetic Sulphonylureas Product Portfolio Table 104. Eli Lilly Recent Development Table 105. Merck & Co Company Information Table 106. Merck & Co Business Overview Table 107. Merck & Co Antidiabetic Sulphonylureas Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Merck & Co Antidiabetic Sulphonylureas Product Portfolio Table 109. Merck & Co Recent Development Table 110. Sanofi Company Information Table 111. Sanofi Business Overview Table 112. Sanofi Antidiabetic Sulphonylureas Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Sanofi Antidiabetic Sulphonylureas Product Portfolio Table 114. Sanofi Recent Development Table 115. Takeda Pharmaceuticals Company Information Table 116. Takeda Pharmaceuticals Business Overview Table 117. Takeda Pharmaceuticals Antidiabetic Sulphonylureas Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Takeda Pharmaceuticals Antidiabetic Sulphonylureas Product Portfolio Table 119. Takeda Pharmaceuticals Recent Development Table 120. Key Raw Materials Table 121. Raw Materials Key Suppliers Table 122. Antidiabetic Sulphonylureas Distributors List Table 123. Antidiabetic Sulphonylureas Customers List Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. Antidiabetic Sulphonylureas Product Image Figure 2. Global Antidiabetic Sulphonylureas Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antidiabetic Sulphonylureas Sales Value (2021-2032) & (US$ Million) Figure 4. Global Antidiabetic Sulphonylureas Sales (2021-2032) & (K Units) Figure 5. Global Antidiabetic Sulphonylureas Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Antidiabetic Sulphonylureas Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. First Generation Antidiabetic Sulphonylureas Image Figure 10. The Second Generation Antidiabetic Sulphonylureas Image Figure 11. The Third Generation Antidiabetic Sulphonylureas Image Figure 12. Global Antidiabetic Sulphonylureas Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Antidiabetic Sulphonylureas Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Antidiabetic Sulphonylureas Sales Volume Share by Type (2021-2032) Figure 15. Global Antidiabetic Sulphonylureas Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Antidiabetic Sulphonylureas Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Antidiabetic Sulphonylureas Sales Value Share by Type (2021-2032) Figure 18. Hospitals Image Figure 19. Clinics Image Figure 20. Other Image Figure 21. Global Antidiabetic Sulphonylureas Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Antidiabetic Sulphonylureas Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Antidiabetic Sulphonylureas Sales Volume Share by Application (2021-2032) Figure 24. Global Antidiabetic Sulphonylureas Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Antidiabetic Sulphonylureas Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Antidiabetic Sulphonylureas Sales Value Share by Application (2021-2032) Figure 27. Global Antidiabetic Sulphonylureas Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Antidiabetic Sulphonylureas Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Antidiabetic Sulphonylureas Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Antidiabetic Sulphonylureas Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Antidiabetic Sulphonylureas Sales Value (2021-2032) & (US$ Million) Figure 32. North America Antidiabetic Sulphonylureas Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Antidiabetic Sulphonylureas Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Antidiabetic Sulphonylureas Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Antidiabetic Sulphonylureas Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Antidiabetic Sulphonylureas Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Antidiabetic Sulphonylureas Sales Value (2021-2032) & (US$ Million) Figure 38. South America Antidiabetic Sulphonylureas Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Antidiabetic Sulphonylureas Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Antidiabetic Sulphonylureas Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Antidiabetic Sulphonylureas Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Antidiabetic Sulphonylureas Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • First Generation Antidiabetic Sulphonylureas
  • The Second Generation Antidiabetic Sulphonylureas
  • The Third Generation Antidiabetic Sulphonylureas
Applications
  • Hospitals
  • Clinics
  • Other
Companies covered
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Novo Nordisk
  • Servier Laboratories
  • AstraZeneca
  • GlaxoSmithKline
  • Pfizer
  • Eli Lilly
  • Merck & Co
  • Sanofi
  • Takeda Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antidiabetic Sulphonylureas Sales Value (2021-2032)
  4. 1.2.2 Global Antidiabetic Sulphonylureas Sales Volume (2021-2032)
  5. 1.2.3 Global Antidiabetic Sulphonylureas Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Antidiabetic Sulphonylureas Market Dynamics
  1. 2.1 Antidiabetic Sulphonylureas Industry Trends
  2. 2.2 Antidiabetic Sulphonylureas Industry Drivers
  3. 2.3 Antidiabetic Sulphonylureas Industry Opportunities and Challenges
  4. 2.4 Antidiabetic Sulphonylureas Industry Restraints
3 Antidiabetic Sulphonylureas Market by Company
  1. 3.1 Global Antidiabetic Sulphonylureas Company Revenue Ranking in 2025
  2. 3.2 Global Antidiabetic Sulphonylureas Revenue by Company (2021-2026)
  3. 3.3 Global Antidiabetic Sulphonylureas Sales Volume by Company (2021-2026)
  4. 3.4 Global Antidiabetic Sulphonylureas Average Price by Company (2021-2026)
  5. 3.5 Global Antidiabetic Sulphonylureas Company Ranking (2024-2026)
  6. 3.6 Global Antidiabetic Sulphonylureas Company Manufacturing Base and Headquarters
  7. 3.7 Global Antidiabetic Sulphonylureas Company Product Type and Application
  8. 3.8 Global Antidiabetic Sulphonylureas Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Antidiabetic Sulphonylureas Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Antidiabetic Sulphonylureas Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Antidiabetic Sulphonylureas Market by Type
  1. 4.1 Antidiabetic Sulphonylureas Type Introduction
  2. 4.1.1 First Generation Antidiabetic Sulphonylureas
  3. 4.1.2 The Second Generation Antidiabetic Sulphonylureas
  4. 4.1.3 The Third Generation Antidiabetic Sulphonylureas
  5. 4.2 Global Antidiabetic Sulphonylureas Sales Volume by Type
  6. 4.2.1 Global Antidiabetic Sulphonylureas Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Antidiabetic Sulphonylureas Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Antidiabetic Sulphonylureas Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Antidiabetic Sulphonylureas Sales Value by Type
  10. 4.3.1 Global Antidiabetic Sulphonylureas Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Antidiabetic Sulphonylureas Sales Value by Type (2021-2032)
  12. 4.3.3 Global Antidiabetic Sulphonylureas Sales Value Share by Type (2021-2032)
5 Antidiabetic Sulphonylureas Market by Application
  1. 5.1 Antidiabetic Sulphonylureas Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Other
  5. 5.2 Global Antidiabetic Sulphonylureas Sales Volume by Application
  6. 5.2.1 Global Antidiabetic Sulphonylureas Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Antidiabetic Sulphonylureas Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Antidiabetic Sulphonylureas Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Antidiabetic Sulphonylureas Sales Value by Application
  10. 5.3.1 Global Antidiabetic Sulphonylureas Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Antidiabetic Sulphonylureas Sales Value by Application (2021-2032)
  12. 5.3.3 Global Antidiabetic Sulphonylureas Sales Value Share by Application (2021-2032)
6 Antidiabetic Sulphonylureas Regional Sales and Value Analysis
  1. 6.1 Global Antidiabetic Sulphonylureas Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Antidiabetic Sulphonylureas Sales by Region (2021-2032)
  3. 6.2.1 Global Antidiabetic Sulphonylureas Sales by Region: 2021-2026
  4. 6.2.2 Global Antidiabetic Sulphonylureas Sales by Region (2027-2032)
  5. 6.3 Global Antidiabetic Sulphonylureas Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Antidiabetic Sulphonylureas Sales Value by Region (2021-2032)
  7. 6.4.1 Global Antidiabetic Sulphonylureas Sales Value by Region: 2021-2026
  8. 6.4.2 Global Antidiabetic Sulphonylureas Sales Value by Region (2027-2032)
  9. 6.5 Global Antidiabetic Sulphonylureas Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Antidiabetic Sulphonylureas Sales Value (2021-2032)
  12. 6.6.2 North America Antidiabetic Sulphonylureas Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Antidiabetic Sulphonylureas Sales Value (2021-2032)
  15. 6.7.2 Europe Antidiabetic Sulphonylureas Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Antidiabetic Sulphonylureas Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Antidiabetic Sulphonylureas Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Antidiabetic Sulphonylureas Sales Value (2021-2032)
  21. 6.9.2 South America Antidiabetic Sulphonylureas Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Antidiabetic Sulphonylureas Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Antidiabetic Sulphonylureas Sales Value Share by Country, 2025 VS 2032
7 Antidiabetic Sulphonylureas Country-level Sales and Value Analysis
  1. 7.1 Global Antidiabetic Sulphonylureas Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Antidiabetic Sulphonylureas Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Antidiabetic Sulphonylureas Sales by Country (2021-2032)
  4. 7.3.1 Global Antidiabetic Sulphonylureas Sales by Country (2021-2026)
  5. 7.3.2 Global Antidiabetic Sulphonylureas Sales by Country (2027-2032)
  6. 7.4 Global Antidiabetic Sulphonylureas Sales Value by Country (2021-2032)
  7. 7.4.1 Global Antidiabetic Sulphonylureas Sales Value by Country (2021-2026)
  8. 7.4.2 Global Antidiabetic Sulphonylureas Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Antidiabetic Sulphonylureas Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Antidiabetic Sulphonylureas Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Antidiabetic Sulphonylureas Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Boehringer Ingelheim
  2. 8.1.1 Boehringer Ingelheim Company Information
  3. 8.1.2 Boehringer Ingelheim Business Overview
  4. 8.1.3 Boehringer Ingelheim Antidiabetic Sulphonylureas Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Boehringer Ingelheim Antidiabetic Sulphonylureas Product Portfolio
  6. 8.1.5 Boehringer Ingelheim Recent Developments
  7. 8.2 Bristol-Myers Squibb
  8. 8.2.1 Bristol-Myers Squibb Company Information
  9. 8.2.2 Bristol-Myers Squibb Business Overview
  10. 8.2.3 Bristol-Myers Squibb Antidiabetic Sulphonylureas Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Bristol-Myers Squibb Antidiabetic Sulphonylureas Product Portfolio
  12. 8.2.5 Bristol-Myers Squibb Recent Developments
  13. 8.3 Novo Nordisk
  14. 8.3.1 Novo Nordisk Company Information
  15. 8.3.2 Novo Nordisk Business Overview
  16. 8.3.3 Novo Nordisk Antidiabetic Sulphonylureas Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Novo Nordisk Antidiabetic Sulphonylureas Product Portfolio
  18. 8.3.5 Novo Nordisk Recent Developments
  19. 8.4 Servier Laboratories
  20. 8.4.1 Servier Laboratories Company Information
  21. 8.4.2 Servier Laboratories Business Overview
  22. 8.4.3 Servier Laboratories Antidiabetic Sulphonylureas Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Servier Laboratories Antidiabetic Sulphonylureas Product Portfolio
  24. 8.4.5 Servier Laboratories Recent Developments
  25. 8.5 AstraZeneca
  26. 8.5.1 AstraZeneca Company Information
  27. 8.5.2 AstraZeneca Business Overview
  28. 8.5.3 AstraZeneca Antidiabetic Sulphonylureas Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 AstraZeneca Antidiabetic Sulphonylureas Product Portfolio
  30. 8.5.5 AstraZeneca Recent Developments
  31. 8.6 GlaxoSmithKline
  32. 8.6.1 GlaxoSmithKline Company Information
  33. 8.6.2 GlaxoSmithKline Business Overview
  34. 8.6.3 GlaxoSmithKline Antidiabetic Sulphonylureas Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 GlaxoSmithKline Antidiabetic Sulphonylureas Product Portfolio
  36. 8.6.5 GlaxoSmithKline Recent Developments
  37. 8.7 Pfizer
  38. 8.7.1 Pfizer Company Information
  39. 8.7.2 Pfizer Business Overview
  40. 8.7.3 Pfizer Antidiabetic Sulphonylureas Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Pfizer Antidiabetic Sulphonylureas Product Portfolio
  42. 8.7.5 Pfizer Recent Developments
  43. 8.8 Eli Lilly
  44. 8.8.1 Eli Lilly Company Information
  45. 8.8.2 Eli Lilly Business Overview
  46. 8.8.3 Eli Lilly Antidiabetic Sulphonylureas Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Eli Lilly Antidiabetic Sulphonylureas Product Portfolio
  48. 8.8.5 Eli Lilly Recent Developments
  49. 8.9 Merck & Co
  50. 8.9.1 Merck & Co Company Information
  51. 8.9.2 Merck & Co Business Overview
  52. 8.9.3 Merck & Co Antidiabetic Sulphonylureas Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Merck & Co Antidiabetic Sulphonylureas Product Portfolio
  54. 8.9.5 Merck & Co Recent Developments
  55. 8.10 Sanofi
  56. 8.10.1 Sanofi Company Information
  57. 8.10.2 Sanofi Business Overview
  58. 8.10.3 Sanofi Antidiabetic Sulphonylureas Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Sanofi Antidiabetic Sulphonylureas Product Portfolio
  60. 8.10.5 Sanofi Recent Developments
  61. 8.11 Takeda Pharmaceuticals
  62. 8.11.1 Takeda Pharmaceuticals Company Information
  63. 8.11.2 Takeda Pharmaceuticals Business Overview
  64. 8.11.3 Takeda Pharmaceuticals Antidiabetic Sulphonylureas Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Takeda Pharmaceuticals Antidiabetic Sulphonylureas Product Portfolio
  66. 8.11.5 Takeda Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Antidiabetic Sulphonylureas Value Chain Analysis
  2. 9.1.1 Antidiabetic Sulphonylureas Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Antidiabetic Sulphonylureas Sales Mode & Process
  6. 9.2 Antidiabetic Sulphonylureas Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Antidiabetic Sulphonylureas Distributors
  9. 9.2.3 Antidiabetic Sulphonylureas Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst